- US12612415utility2026Stereoselective Process for Preparing Substituted Polycyclic Pyridone0 cites
- US12584132utility2026Nucleic Acid Drug Targeting MURF10 cites
- US12577241utility2026Polycyclic Pyridopyrazine Derivative0 cites
- US12570627utility2026Pharmaceutical Composition in Which Production of Impurities Is Suppressed0 cites
- US12527775utility2026Heteroaromatic Derivatives Having Serotonin Receptor Binding Activity0 cites
- US12491229utility2025Stabilized Peptide Composition0 cites
- US12454533utility2025Fused Ring Derivative Having MGAT-2 Inhibitory Activity0 cites
- US12455270utility2025Mesh for Dissolution Test0 cites
- US12427156utility2025Solid Dosage Form Having Excellent Stability0 cites
- US12400468utility2025Program Generation Assisting System for Assisting Generation of Program for Analyzing Clinical Trial0 cites
- US12351804utility2025Production Method for Bifurcated Lipid-linked Oligonucleotide, and Intermediate0 cites
- US12350377utility2025Preparation Containing 6,7-unsaturated-7-carbamoyl Morphinan Derivatives0 cites
- US12312327utility2025Crystal of 1,3,5-triazine Derivative or Solvate Thereof and Method for Producing Same0 cites
- US12227509utility2025Dihydropyrazolopyrazinone Derivative Having MGAT2 Inhibitory Activity0 cites
- US12139489utility2024Polycyclic Carbamoylpyridone Derivative0 cites
- US12098151utility2024Arenavirus Growth Inhibitor Comprising Polycyclic Carbamoyl Pyridone Derivative0 cites
- US12064438utility2024Pharmaceutical Preparation Excellent in Light Stability and Dissolution Property0 cites
Page 1 of 2Next →